Management of ascites due to gastrointestinal malignancy (Q35789515)

10 August 2017

1 reference

3 April 2019

Management of ascites due to gastrointestinal malignancy (English)

1 reference

10 August 2017

1 reference

3 April 2019

1 reference

3 April 2019

1 reference

Muhammad W Saif

1 reference

10 August 2017

Imran A P Siddiqui

series ordinal

1 reference

10 August 2017

Muhammad A Sohail

series ordinal

1 reference

10 August 2017

publication date

1 September 2009

1 reference

10 August 2017

published in

Annals of Saudi Medicine

2 references

10 August 2017

3 April 2019

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

369-377

1 reference

Creative Commons Attribution 2.0 Generic

10 August 2017

1 reference

on focus list of Wikimedia project

3 April 2019

copyrighted

0 references

ScienceSource

0 references

cites work

Fluid retention in cirrhosis: pathophysiology and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Peritoneovenous shunts for palliation of malignant ascites

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Malignant ascites: systematic review and guideline for treatment.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Malignant effusions are sources of fibronectin and other promigratory and proinvasive components

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Management of cirrhosis and ascites

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

The development of clinical guidelines on paracentesis for ascites related to malignancy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Octreotide as an agent for the relief of malignant ascites in palliative care patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Clinical practice guidelines for the management of cirrhotic patients with ascites. Committee on Ascites of the Italian Association for the Study of the Liver

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Intraperitoneal pressures and clinical parameters of total paracentesis for palliation of symptomatic ascites in ovarian cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Peritoneovenous shunting for malignant ascites.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Managing ascites via the Tenckhoff catheter

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Malignant ascites: a 2-year review from a teaching hospital

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

27 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

27 July 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Care of patients with ascites

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Intraperitoneal interferon in the management of malignant ascites

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Peritoneovenous shunts for palliation of the patient with malignant ascites

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

On the treatment and prognosis of malignant ascites: is the survival time determined when the abdominal paracentesis is needed?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Human leukocyte interferon therapy for advanced ovarian carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

The effect of large volume paracentesis on plasma volume--a cause of hypovolemia?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Intraperitoneal recombinant alpha 2-interferon for 'salvage' immunotherapy in persistent epithelial ovarian cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Malignant ascites. Clinical and experimental observations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Ascitic fluid analysis in malignancy-related ascites

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Renaissance of paracentesis in the treatment of ascites

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Large-volume paracentesis in treatment of ascites

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Abdominal paracentesis for malignant ascites

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Treatment of malignant ascites in patients with advanced cancer: peritoneovenous shunt versus paracentesis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Malignant ascites: new concepts in pathophysiology, diagnosis, and management

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Emerging indications for octreotide therapy, Part 1.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290049

Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases

25 September 2018

1 reference

12 December 2020

Paracentesis--an effective method of symptom control in the palliative care setting?

1 reference

12 December 2020

A simplified correction of subclavian steal syndrome

1 reference

12 December 2020

Control of malignant ascites with spironolactone

1 reference

12 December 2020

Peritoneovenous shunts in the management of malignant ascites

1 reference

12 December 2020

Control of malignant ascites by peritoneovenous shunting

1 reference

12 December 2020

Surgical and pathologic complications associated with peritoneovenous shunts in management of malignant ascites

1 reference

12 December 2020

Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascites

1 reference

12 December 2020

Evaluation of fibronectin as a marker of malignant ascites

1 reference

12 December 2020

Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites

1 reference

12 December 2020

A survey of practice in management of malignant ascites

1 reference

12 December 2020

Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract

1 reference

12 December 2020

EUS-guided paracentesis for the diagnosis of malignant ascites

1 reference

12 December 2020

Identifiers

DOI

10.4103/0256-4947.55167

1 reference

release_gw7lk5tu7zbsvc2gzt2vzz64gi

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gw7lk5tu7zbsvc2gzt2vzz64gi

24 November 2022

mapped directly with Wikidata item

PMC publication ID

3290049

1 reference

10 August 2017

1 reference